These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22239907)

  • 1. COPD exacerbations in general practice: variability in oral prednisolone courses.
    de Vries M; Berendsen AJ; Bosveld HE; Kerstjens HA; van der Molen T
    BMC Fam Pract; 2012 Jan; 13():3. PubMed ID: 22239907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.
    Walters JA; Tan DJ; White CJ; Wood-Baker R
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD006897. PubMed ID: 29553157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.
    Walters JA; Tan DJ; White CJ; Wood-Baker R
    Cochrane Database Syst Rev; 2014 Dec; (12):CD006897. PubMed ID: 25491891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of ICS/LABA prescribing in COPD patients: a study from general practice.
    Drivenes E; Ostrem A; Melbye H
    BMC Fam Pract; 2014 Mar; 15():42. PubMed ID: 24597538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.
    Walters JA; Wang W; Morley C; Soltani A; Wood-Baker R
    Cochrane Database Syst Rev; 2011 Oct; (10):CD006897. PubMed ID: 21975757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COPD patients prescribed inhaled corticosteroid in general practice: Based on disease characteristics according to guidelines?
    Savran O; Godtfredsen N; Sørensen T; Jensen C; Ulrik CS
    Chron Respir Dis; 2019; 16():1479973119867949. PubMed ID: 31431060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double-blind placebo-controlled trial.
    van Velzen P; Ter Riet G; Bresser P; Baars JJ; van den Berg BTJ; van den Berg JWK; Brinkman P; Dagelet JWF; Daniels JMA; Groeneveld-Tjiong DRGL; Jonkers RE; van Kan C; Krouwels FH; Pool K; Rudolphus A; Sterk PJ; Prins JM
    Lancet Respir Med; 2017 Jun; 5(6):492-499. PubMed ID: 28483402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changed terms for drug payment influenced GPs' diagnoses and prescribing practice for inhaled corticosteroids.
    Dalbak LG; Rognstad S; Melbye H; Straand J
    Eur J Gen Pract; 2013 Jun; 19(2):106-10. PubMed ID: 23560809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice.
    Chalmers JD; Tebboth A; Gayle A; Ternouth A; Ramscar N
    NPJ Prim Care Respir Med; 2017 Jun; 27(1):43. PubMed ID: 28663549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD. A double-blind, randomised, non-inferiority, parallel-group, multicentre study.
    Ställberg B; Selroos O; Vogelmeier C; Andersson E; Ekström T; Larsson K
    Respir Res; 2009 Feb; 10(1):11. PubMed ID: 19228428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral or IV prednisolone in the treatment of COPD exacerbations: a randomized, controlled, double-blind study.
    de Jong YP; Uil SM; Grotjohan HP; Postma DS; Kerstjens HA; van den Berg JW
    Chest; 2007 Dec; 132(6):1741-7. PubMed ID: 17646228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different oral corticosteroid regimens for acute asthma.
    Normansell R; Kew KM; Mansour G
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD011801. PubMed ID: 27176676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trial.
    Ramakrishnan S; Jeffers H; Langford-Wiley B; Davies J; Thulborn SJ; Mahdi M; A'Court C; Binnian I; Bright S; Cartwright S; Glover V; Law A; Fox R; Jones A; Davies C; Copping D; Russell RE; Bafadhel M
    Lancet Respir Med; 2024 Jan; 12(1):67-77. PubMed ID: 37924830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial.
    Sivapalan P; Lapperre TS; Janner J; Laub RR; Moberg M; Bech CS; Eklöf J; Holm FS; Armbruster K; Sivapalan P; Mosbech C; Ali AKM; Seersholm N; Wilcke JT; Brøndum E; Sonne TP; Rønholt F; Andreassen HF; Ulrik CS; Vestbo J; Jensen JS
    Lancet Respir Med; 2019 Aug; 7(8):699-709. PubMed ID: 31122894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do decision support systems influence variation in prescription?
    de Jong JD; Groenewegen PP; Spreeuwenberg P; Westert GP; de Bakker DH
    BMC Health Serv Res; 2009 Jan; 9():20. PubMed ID: 19183464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of treatment with antibiotics and systemic corticosteroids for acute exacerbations of asthma and chronic obstructive pulmonary disease in primary care.
    Salwan AA; Spigt M; Laue J; Melbye H
    BMC Fam Pract; 2015 Mar; 16():40. PubMed ID: 25887285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care.
    Bathoorn E; Groenhof F; Hendrix R; van der Molen T; Sinha B; Kerstjens HA; Friedrich AW; Kocks JW
    Int J Chron Obstruct Pulmon Dis; 2017; 12():285-290. PubMed ID: 28144133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value and utility of oral steroid testing for treatment of COPD in primary care: the COOPT study.
    Chavannes NH; Schermer TR; Wouters EF; Akkermans RP; Dekhuijzen RP; Muris JW; van Weel C; van Schayck OC
    Int J Chron Obstruct Pulmon Dis; 2009; 4():431-6. PubMed ID: 20037682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-life use of fluticasone propionate/salmeterol in patients with chronic obstructive pulmonary disease: a French observational study.
    Roche N; Pribil C; Van Ganse E; Serrier P; Housset B; Poirier D; Texier N; Schück S; Boucot I
    BMC Pulm Med; 2014 Apr; 14():56. PubMed ID: 24694050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inverse relationship between nonadherence to original GOLD treatment guidelines and exacerbations of COPD.
    Foda HD; Brehm A; Goldsteen K; Edelman NH
    Int J Chron Obstruct Pulmon Dis; 2017; 12():209-214. PubMed ID: 28123293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.